Goldman Sachs’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-150,579
| Closed | -$44.9K | – | 5105 |
|
2023
Q2 | $44.9K | Buy |
150,579
+88,446
| +142% | +$26.4K | ﹤0.01% | 4683 |
|
2023
Q1 | $26.9K | Sell |
62,133
-14,945
| -19% | -$6.46K | ﹤0.01% | 4850 |
|
2022
Q4 | $91K | Buy |
77,078
+47,996
| +165% | +$56.6K | ﹤0.01% | 4697 |
|
2022
Q3 | $67K | Buy |
+29,082
| New | +$67K | ﹤0.01% | 4999 |
|
2022
Q2 | – | Sell |
-26,807
| Closed | -$258K | – | 5939 |
|
2022
Q1 | $258K | Buy |
+26,807
| New | +$258K | ﹤0.01% | 4960 |
|
2021
Q3 | – | Sell |
-333,889
| Closed | -$3.28M | – | 5598 |
|
2021
Q2 | $3.28M | Buy |
333,889
+196,489
| +143% | +$1.93M | ﹤0.01% | 3111 |
|
2021
Q1 | $1.33M | Buy |
+137,400
| New | +$1.33M | ﹤0.01% | 3713 |
|